1. Benjamin, EJ, Muntner, P, Alonso, A, et al. Heart disease and stroke statistics-2019 update: a report from the American heart association. Circulation. 2019;139:e56-e528.
Google Scholar | Crossref | Medline2. Yancy, CW, Jessup, M, Bozkurt, B, et al. ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. Circulation. 2013;128:1810-1852.
Google Scholar | Crossref | Medline | ISI3. Writing Committee, M, Yancy, CW, Jessup, M, et al. ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: An update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart failure society of America. Circulation. 2016;134:e282-e293.
Google Scholar | Medline4. Yancy, CW, Jessup, M, Bozkurt, B, et al. ACC/AHA/HFS`A focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart failure society of America. J Am Coll Cardiol. 2017;70:776-803.
Google Scholar | Crossref | Medline5. Hollenberg, SM, Warner Stevenson, L, et al. ACC expert consensus decision pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure: a report of the american college of cardiology solution set oversight committee. J Am Coll Cardiol. 2019;74:1966-2011.
Google Scholar | Crossref | Medline Maddox, TM, Januzzi, JL, Allen, LA, et al. 2021 Update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American College of cardiology solution set oversight committee. J Am Coll Cardiol 2021;77(6):772-810.
Google Scholar | Crossref | Medline7. Gayat, E, Arrigo, M, Littnerova, S, et al. Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study. Eur J Heart Fail. 2018;20:345-354.
Google Scholar | Crossref | Medline8. Tran, RH, Aldemerdash, A, Chang, P, et al. Guideline-directed medical therapy and survival following hospitalization in patients with heart failure. Pharmacotherapy. 2018;38:406-416.
Google Scholar | Crossref | Medline9. Peri-Okonny, PA, Mi, X, Khariton, Y, et al. Target doses of heart failure medical therapy and blood pressure: insights from the CHAMP-HF registry. JACC Heart Fail. 2019;7:350-358.
Google Scholar | Crossref | Medline10. Bhagat, AAA, Greene, SJ, Vaduganathan, M, Fonarow, GC, Butler, J. Initiation, continuation, switching, and withdrawal of heart failure medical therapies during hospitalization. JACC Heart Fail. 2019;7:1-12.
Google Scholar | Crossref | Medline McMurray, JJ, Packer, M, Desai, AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014;371(11):993-1004.
Google Scholar | Crossref | Medline | ISI12. Schuller, D, Lynch, JP, Fine, D. Protocol-guided diuretic management: comparison of furosemide by continuous infusion and intermittent bolus. Crit Care Med. 1997;25:1969-1975.
Google Scholar | Crossref | Medline | ISI13. Felker, GM, Lee, KL, Bull, DA, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364:797-805.
Google Scholar | Crossref | Medline | ISI14. Imiela, T, Budaj, A. Acetazolamide as add-on diuretic therapy in exacerbations of chronic heart failure: a pilot study. Clin Drug Investig. 2017;37:1175-1181.
Google Scholar | Crossref | Medline15. Velazquez, EJ, Morrow, DA, DeVore, AD, et al. Angiotensin-neprilysin inhibition in acute decompensated heart failure. N Engl J Med. 2019;380:539-548.
Google Scholar | Crossref | Medline16. DeVore, AD, Braunwald, E, Morrow, DA, et al. Initiation of angiotensin-neprilysin inhibition after acute decompensated heart failure: secondary analysis of the open-label extension of the PIONEER-HF trial. JAMA Cardiol. 2019;5:4665.
Google Scholar17. Morrow, DA, Velazquez, EJ, DeVore, AD, et al. Clinical outcomes in patients with acute decompensated heart failure randomly assigned to sacubitril/valsartan or enalapril in the PIONEER-HF trial. Circulation. 2019;139:2285-2288.
Google Scholar | Crossref | Medline18. Damman, K, Beusekamp, JC, Boorsma, EM, et al. Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF). Eur J Heart Fail. 2020;22(4):713-722.
Google Scholar | Crossref | Medline19. Cox, ZL, Collins, SP, Aaron, M, et al. Efficacy and safety of dapagliflozin in acute heart failure: rationale and design of the DICTATE-AHF trial. Am Heart J. 2021;232:116-124.
Google Scholar | Crossref | Medline